Considering the fact that NMDA receptors are also involved in the amnestic effects of scopolamine [58,70], it is likely that the reversal of scopolamine amnesia by administration of CB1 receptor antagonists, demonstrated in the presented study, may be just a result of the interaction between CB1 and NMDA receptors. The gene discussed is CNR1; the disease is amnesia.